Inherent in the application of advances in biomedical science to nuclear medicine is the
concept of molecular targeting: the in vivo concentration of labeled tracer by a gene, its …

Nuclear medicine is a multidisciplinary field that develops and uses instrumentation and
tracers (radiopharmaceuticals) to study physiological processes and noninvasively …

Imaging and therapy of cancer using radionuclide-labelled compounds is surveyed. The
current state of knowledge concerning the cancerous process, the subtle differences …

This collection of reviews and papers on targeted radionuclide therapy provides a snapshot
of the current status of modern clinical applications of therapeutic nuclear medicine. The …

Radiopharmaceuticals for molecular imaging involve careful consideration of the following
two factors: radionuclide selection and specificity to the molecular target. In selecting a …

Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Targeted radionuclide therapy (TRT) seeks molecular and functional targets within patient
tumor sites. A number of agents have been constructed and labeled with beta, alpha, and …

Owing to their large size proteinaceous drugs offer higher operative information content
compared to the small molecules that correspond to the traditional understanding of …

This review highlights recent progress in the development of anticancer
radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of …

Journal of Nuclear Medicine of the article by Cescato et al.(1) prompts some considerations
on receptorguided tumor targeting with radionuclides. The term receptor-guided tumor …